...
首页> 外文期刊>Analytical and bioanalytical chemistry >What about the herb? A new metabolomics approach for synthetic cannabinoid drug testing
【24h】

What about the herb? A new metabolomics approach for synthetic cannabinoid drug testing

机译:草本怎么样? 一种新的合成大麻素药物检测的新代谢组方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Synthetic cannabinoids (SCs) are consumed as legal alternative to cannabis and often allow passing drug-screening tests. Their rapid transience on the drug scene, combined with their mostly unknown metabolic profiles, creates a scenario with constantly moving analytical targets, making their monitoring and identification challenging. The development of fast screening strategies for SCs, not directly focused on their chemical structure, as an alternative to the commonly applied target acquisition methods, would be highly appreciated in forensic and public health laboratories. An innovative untargeted metabolomics approach, focused on herbal components commonly used for 'spice' products, was applied. Saliva samples of healthy volunteers were collected at pre-dose and after smoking herbal components and analysed by high-resolution mass spectrometry. The data obtained, combined with appropriate statistical analysis, allowed to highlight and elucidate two markers (scopoletin and N,N-bis(2-hydroxyethyl)dodecylamine), which ratio permitted to differentiate herbal smokers from non-smokers. The proposed strategy will allow discriminating potential positives, on the basis of the analysis of two markers identified in the herbal blends. This work is presented as a step forward in SC drug testing, promoting a smart first-line screening approach, which will allow reducing the number of samples to be further investigated by more sophisticated HRMS methods.
机译:合成大麻素(SCS)被用作大麻的合法替代品,并且通常允许通过药物筛选测试。他们对药物现场的快速性交,结合其大多数未知的代谢配置文件,创造了一个不断移动的分析目标的场景,并使他们的监测和识别具有挑战性。在法医学和公共卫生实验室中,将在常用目标采集方法的替代方面直接专注于SCS的快速筛选策略的开发,这将在法医和公共卫生实验室中受到高度赞赏。应用了一种创新的未标准化的代谢组,专注于常用于“香料”产品的草药成分。在预剂量和吸烟草药组分中收集健康志愿者的唾液样本,并通过高分辨率质谱分析。获得的数据与适当的统计分析结合允许突出和阐明两种标记物(Scopoletin和N,N-Bis(2-羟基乙基)十二烷基胺),其允许与非吸烟者区分中草虫吸烟者的比例。拟议的策略将在分析草药混合物中鉴定的两种标记的基础上,允许歧视潜在的阳性。这项工作作为SC药物测试的一步,促进了智能一线筛选方法,这将允许通过更复杂的HRMS方法减少进一步研究的样品的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号